| 1 |
34848454 | Intravenous Administration of Dehydroxymethylepoxyquinomicin With Polymer Enhances the Inhibition of Pancreatic Carcinoma Growth in Mice. | 2021 Dec |
2 |
| 2 |
32377746 | Anti‑inflammatory effects of the NF‑κB inhibitor dehydroxymethylepoxyquinomicin on ARPE‑19 cells. | 2020 Jul |
3 |
| 3 |
30724631 | Dehydroxymethylepoxyquinomicin suppresses atopic dermatitis-like lesions in a stratum corneum-removed murine model through NF-κB inhibition. | 2019 Feb |
5 |
| 4 |
31446998 | Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC. | 2019 Sep |
2 |
| 5 |
31653220 | Role of nuclear factor-kappa B in feline injection site sarcoma. | 2019 Oct 25 |
1 |
| 6 |
29141555 | Antineoplastic Effects of NF-κB Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines. | 2018 |
5 |
| 7 |
28003138 | Rational design, synthesis and in vitro evaluation of novel exo-methylene butyrolactone salicyloylamide as NF-κB inhibitor. | 2017 Feb 1 |
2 |
| 8 |
28107418 | NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells. | 2017 |
2 |
| 9 |
26802647 | Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells. | 2016 Jan 21 |
3 |
| 10 |
27831555 | Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response. | 2016 Nov 10 |
3 |
| 11 |
28078047 | Inhibition of NF-kappaB with Dehydroxymethylepoxyquinomicin modifies the function of human peritoneal mesothelial cells. | 2016 |
2 |
| 12 |
25519802 | Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts. | 2015 Apr |
6 |
| 13 |
25706397 | Inhibition of canonical NF-κB nuclear localization by (-)-DHMEQ via impairment of DNA binding. | 2015 |
4 |
| 14 |
25926105 | Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer. | 2015 Apr 29 |
2 |
| 15 |
26502701 | INHIBITOR OF THE TRANSCRIPTION FACTOR NF-κB, DHMEQ, ENHANCES THE EFFECT OF PACLITAXEL ON CELLS OF ANAPLASTIC THYROID CARCINOMA IN VITRO AND IN VIVO. | 2015 May-Jun |
2 |
| 16 |
24724610 | DSE-FRET: A new anticancer drug screening assay for DNA binding proteins. | 2014 Jul |
2 |
| 17 |
24867687 | Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor. | 2014 Jun 10 |
2 |
| 18 |
25025901 | Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC. | 2014 Oct |
1 |
| 19 |
25170898 | Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy. | 2014 |
5 |
| 20 |
23504230 | Screening of new bioactive metabolites for diabetes therapy. | 2013 Apr |
1 |
| 21 |
23533755 | Inhibition of NF- κ B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ -Radiation Cytotoxicity in Glioblastoma Cells. | 2013 |
3 |
| 22 |
23633516 | p53 dysfunction precedes the activation of nuclear factor-κB during disease progression in mice expressing Tax, a human T-cell leukemia virus type 1 oncoprotein. | 2013 Sep |
3 |
| 23 |
23690471 | Pleiotropic potential of dehydroxymethylepoxyquinomicin for NF-κB suppression via reactive oxygen species and unfolded protein response. | 2013 Jun 15 |
12 |
| 24 |
24762223 | Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells. | 2013 |
8 |
| 25 |
22343223 | The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. | 2012 Sep 1 |
4 |
| 26 |
22447108 | Involvement of NF-κB-mediated expression of galectin-3-binding protein in TNF-α-induced breast cancer cell adhesion. | 2012 Jun |
2 |
| 27 |
22975513 | Interferon gamma induces steroid sulfatase expression in human keratinocytes. | 2012 |
2 |
| 28 |
22976334 | A chemo-enzymatic expeditious route to racemic dihexanoyl (2R*,3R*,4R*)-dehydroxymethylepoxyquinomycin (DHMEQ), the precursor for lipase-catalyzed synthesis of the potent nuclear factor-κB inhibitor, (2S,3S,4S)-DHMEQ. | 2012 |
1 |
| 29 |
21288284 | Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion. | 2011 May |
1 |
| 30 |
21459660 | Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo. | 2011 May |
2 |
| 31 |
21723080 | Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ. | 2011 Jul |
3 |
| 32 |
21963506 | Coffee induces breast cancer resistance protein expression in Caco-2 cells. | 2011 |
1 |
| 33 |
22057485 | Role of NF-κB/Snail/RKIP loop in the response of tumor cells to photodynamic therapy. | 2011 Sep |
1 |
| 34 |
19560263 | A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. | 2010 Jan 1 |
4 |
| 35 |
19997106 | Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. | 2010 Jan 5 |
2 |
| 36 |
20156648 | Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines. | 2010 Apr |
7 |
| 37 |
20638688 | Donor pretreatment with DHMEQ improves islet transplantation. | 2010 Sep |
3 |
| 38 |
20801656 | A new NF-κB inhibitor based on the amino-epoxyquinol core of DHMEQ. | 2010 Oct 1 |
2 |
| 39 |
21059341 | Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. | 2010 Dec 3 |
2 |
| 40 |
19275643 | Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. | 2009 |
7 |
| 41 |
19843864 | Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. | 2009 Nov 1 |
2 |
| 42 |
18217958 | DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of dendritic cells. | 2008 Jun |
3 |
| 43 |
18406579 | DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts. | 2008 Sep |
4 |
| 44 |
18538617 | Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ. | 2008 Jun |
5 |
| 45 |
18760530 | Growth suppression and apoptosis induction in synovial sarcoma cell lines by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ). | 2008 Dec 18 |
3 |
| 46 |
18782563 | Identification of the RelA domain responsible for action of a new NF-kappaB inhibitor DHMEQ. | 2008 Nov 14 |
9 |
| 47 |
17306602 | Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent. | 2007 Feb-Apr |
6 |
| 48 |
17466373 | Targeting NF-kappaB and induction of apoptosis by novel NF-kappaB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells. | 2007 Nov |
6 |
| 49 |
16002138 | In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102. | 2006 Jan |
4 |
| 50 |
16355386 | Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines. | 2006 Feb |
5 |